Literature DB >> 28076614

Association between asthma and female sex hormones.

Raquel Prudente de Carvalho Baldaçara1, Ivaldo Silva2.   

Abstract

CONTEXT AND
OBJECTIVE: : The relationship between sex hormones and asthma has been evaluated in several studies. The aim of this review article was to investigate the association between asthma and female sex hormones, under different conditions (premenstrual asthma, use of oral contraceptives, menopause, hormone replacement therapy and pregnancy). DESIGN AND
SETTING: : Narrative review of the medical literature, Universidade Federal do Tocantins (UFT) and Universidade Federal de São Paulo (Unifesp).
METHODS: : We searched the CAPES journal portal, a Brazilian platform that provides access to articles in the MEDLINE, PubMed, SciELO, and LILACS databases. The following keywords were used based on Medical Subject Headings: asthma, sex hormones, women and use of oral contraceptives.
RESULTS: : The associations between sex hormones and asthma remain obscure. In adults, asthma is more common in women than in men. In addition, mortality due to asthma is significantly higher among females. The immune system is influenced by sex hormones: either because progesterone stimulates progesterone-induced blocking factor and Th2 cytokines or because contraceptives derived from progesterone and estrogen stimulate the transcription factor GATA-3.
CONCLUSIONS: : The associations between asthma and female sex hormones remain obscure. We speculate that estrogen fluctuations are responsible for asthma exacerbations that occur in women. Because of the anti-inflammatory action of estrogen, it decreases TNF-α production, interferon-γ expression and NK cell activity. We suggest that further studies that highlight the underlying physiopathological mechanisms contributing towards these interactions should be conducted.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28076614     DOI: 10.1590/1516-3180.2016.011827016

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  7 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The impact of 17β-estradiol and progesterone therapy on peripheral blood mononuclear cells of asthmatic patients.

Authors:  Leila Nejatbakhsh Samimi; Morteza Fallahpour; Majid Khoshmirsafa; Seyed Ali Javad Moosavi; Paria Bayati; Rasoul Baharlou; Reza Falak
Journal:  Mol Biol Rep       Date:  2020-12-14       Impact factor: 2.316

Review 3.  Gender aspects and influence of hormones on bronchial asthma - Secondary publication and update.

Authors:  Iris Koper; Karin Hufnagl; Rainer Ehmann
Journal:  World Allergy Organ J       Date:  2017-12-27       Impact factor: 4.084

Review 4.  Sex Bias in Asthma Prevalence and Pathogenesis.

Authors:  Ruchi Shah; Dawn C Newcomb
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

5.  The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study.

Authors:  Giulia Scioscia; Giovanna Elisiana Carpagnano; Donato Lacedonia; Piera Soccio; Carla Maria Irene Quarato; Luigia Trabace; Paolo Fuso; Maria Pia Foschino Barbaro
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

6.  Effect of aerobic exercise training on asthma control in postmenopausal women (the ATOM-study): protocol for an outcome assessor, randomised controlled trial.

Authors:  Erik Sören Halvard Hansen; Morten Hostrup; Hanne Kruuse Rasmusen; Ylva Hellsten; Vibeke Backer
Journal:  BMJ Open       Date:  2021-04-22       Impact factor: 2.692

Review 7.  Perimenstrual Asthma in Adolescents: A Shared Condition in Pediatric and Gynecological Endocrinology.

Authors:  Valeria Calcaterra; Rossella Elena Nappi; Andrea Farolfi; Lara Tiranini; Virginia Rossi; Corrado Regalbuto; Gianvincenzo Zuccotti
Journal:  Children (Basel)       Date:  2022-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.